Literature DB >> 28831619

Important role of calcium chloride in preventing carbon monoxide generation during desflurane degradation with alkali hydroxide-free carbon dioxide absorbents.

Takahiro Ando1, Atsushi Mori2, Rie Ito1, Kimitoshi Nishiwaki3.   

Abstract

We investigated whether calcium chloride (CaCl2), a supplementary additive in carbon dioxide (CO2) absorbents, could affect carbon monoxide (CO) production caused by desflurane degradation, using a Japanese alkali-free CO2 absorbent Yabashi Lime®-f (YL-f), its CaCl2-free and 1% CaCl2-added derivatives, and other commercially available alkali-free absorbents with or without CaCl2. The reaction between 1 L of desflurane gas (3-10%) and 20 g of desiccated specimen was performed in an artificial closed-circuit anesthesia system for 3 min at 20 or 40 °C. The CO concentration was measured using a gas chromatograph equipped with a semiconductor sensor detector. The systems were validated by detecting dose-dependent CO production with an alkali hydroxide-containing CO2 absorbent, Sodasorb®. Compared with YL-f, the CaCl2-free derivative caused the production of significantly more CO, while the 1% CaCl2-added derivative caused the production of a comparable amount of CO. These phenomena were confirmed using commercially available absorbents AMSORB® PLUS, an alkali-free absorbent with CaCl2, and LoFloSorb™, an alkali-free absorbent without CaCl2. These results suggest that CaCl2 plays an important role in preventing CO generation caused by desflurane degradation with alkali hydroxide-free CO2 absorbents like YL-f.

Entities:  

Keywords:  Calcium chloride; Carbon monoxide production; Desflurane; Desiccated carbon dioxide absorbents; Yabashi Lime®-f

Mesh:

Substances:

Year:  2017        PMID: 28831619     DOI: 10.1007/s00540-017-2397-0

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  13 in total

1.  Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.

Authors:  M M R F Struys; M P L A Bouche; G Rolly; Y D I Vandevivere; D Dyzers; W Goeteyn; L F M Versichelen; J F P Van Bocxlaer; E P Mortier
Journal:  Anaesthesia       Date:  2004-06       Impact factor: 6.955

2.  Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.

Authors:  Evan D Kharasch; Karen M Powers; Alan A Artru
Journal:  Anesthesiology       Date:  2002-01       Impact factor: 7.892

Review 3.  Formation and toxicity of anesthetic degradation products.

Authors:  M W Anders
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

4.  Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems.

Authors:  J M Murray; C W Renfrew; A Bedi; C B McCrystal; D S Jones; J P Fee
Journal:  Anesthesiology       Date:  1999-11       Impact factor: 7.892

5.  The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.

Authors:  M A Neumann; M J Laster; R B Weiskopf; D H Gong; R Dudziak; H Förster; E I Eger
Journal:  Anesth Analg       Date:  1999-09       Impact factor: 5.108

6.  Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme.

Authors:  Z X Fang; E I Eger; M J Laster; B S Chortkoff; L Kandel; P Ionescu
Journal:  Anesth Analg       Date:  1995-06       Impact factor: 5.108

7.  Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: comparison of Drägersorb Free, Amsorb, and Sodasorb II.

Authors:  Shunji Kobayashi; Hiromichi Bito; Yukako Obata; Takasumi Katoh; Shigehito Sato
Journal:  J Clin Anesth       Date:  2003-02       Impact factor: 9.452

8.  Performance of four carbon dioxide absorbents in experimental and clinical settings.

Authors:  M Yamakage; K Takahashi; M Takahashi; J-I Satoh; A Namiki
Journal:  Anaesthesia       Date:  2009-03       Impact factor: 6.955

9.  Carbon monoxide production from five volatile anesthetics in dry sodalime in a patient model: halothane and sevoflurane do produce carbon monoxide; temperature is a poor predictor of carbon monoxide production.

Authors:  Christiaan Keijzer; Roberto Sgm Perez; Jaap J De Lange
Journal:  BMC Anesthesiol       Date:  2005-06-02       Impact factor: 2.217

10.  Performance of a new carbon dioxide absorbent, Yabashi lime® as compared to conventional carbon dioxide absorbent during sevoflurane anesthesia in dogs.

Authors:  Kei Kondoh; Ayman Atiba; Kiyoshi Nagase; Shizuko Ogawa; Takashi Miwa; Teruya Katsumata; Hiroshi Ueno; Yuji Uzuka
Journal:  J Vet Med Sci       Date:  2015-05-04       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.